# Normobaric Hyperoxygenation for Prevention of Contrast Induced Nephropathy

> **NCT01448889** · NA · UNKNOWN · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 180 (estimated)

## Conditions studied

- Nephropathy

## Interventions

- **DRUG:** 100% oxigen
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01448889
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-09
- **Primary completion:** 2012-09
- **Final completion:** 2012-12
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2011-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01448889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01448889, "Normobaric Hyperoxygenation for Prevention of Contrast Induced Nephropathy". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01448889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*